Dual Energy Catheter Ablation for PVCs
(DUAL-PVC Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this research is to understand whether a dual-energy catheter ablation system that uses radiofrequency (RF) and pulsed-field (PF) energy can safely and effectively treat premature ventricular contractions (PVCs).
Who Is on the Research Team?
Konstantinos Siontis, MD
Principal Investigator
Mayo Clinic
Are You a Good Fit for This Trial?
This trial is for people who have premature ventricular contractions (PVCs), a type of irregular heartbeat. Specific inclusion and exclusion criteria are not listed, but generally participants should be adults with PVCs and without major health issues that would make the procedure unsafe.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Dual Energy THERMOCOOL SMARTTOUCH™ SF (STSF) Bi-Directional Navigation catheter with TRUPULSE™ Generator
Trial Overview
The study is testing a new catheter ablation system that uses both radiofrequency (RF) and pulsed-field (PF) energy to treat PVCs. The goal is to see if this dual-energy approach can safely reduce abnormal heartbeats.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Participants are assigned to receive radiofrequency (RF) followed by pulsed-field (PF) at each selected treatment site. For each PF treatment, 24 PF bursts are delivered. Up to three stacked lesions may be performed at the same location.
Participants are assigned to receive pulsed-field (PF) alone at each selected treatment site. For each PF treatment, 24 PF bursts are delivered. Up to three stacked lesions may be performed at the same location.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Konstantinos Siontis
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.